NRSF/REST confers transcriptional repression of the GPR10 gene via a putative NRSE/RE-1 located in the 5′ promoter region  by Kemp, Daniel M. et al.
NRSF/REST confers transcriptional repression of the GPR10 gene via
a putative NRSE/RE-1 located in the 5P promoter region
Daniel M. Kemp, Julia C. Lin, Mariano Ubeda, Joel F. Habener
Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Howard Hughes Medical Institute, Harvard Medical School,
55 Fruit Street WEL320, Boston, MA 02114, USA
Received 27 August 2002; accepted 24 September 2002
First published online 4 October 2002
Edited by Jacques Hanoune
Abstract The G protein-coupled receptor GPR10 is highly lo-
calized to areas of the brain. In an e¡ort to reveal transcrip-
tional determinants of this tissue speci¢city, we recognized a
putative NRSE (neuron-restrictive silencer element) located in
the 5P promoter region of the gene. The cognate NRSE binding
protein NRSF (neuron-restrictive silencer factor) restricts gene
expression to mature neurons and endocrine cells by repressing
their transcription in non-neuronal/-endocrine cells. In cell lines
where NRSF-mediated gene repression has been functionally
established, the activity of the GPR10 promoter was repressed
in a manner consistent with NRSE-dependent regulation. A
speci¢c point mutation to confer non-functionality of the
NRSE revealed a 10-fold de-repression of reporter gene expres-
sion. In contrast, in the GPR10-expressing cell line GH3,
mRNA transcripts of NRSF were undetectable and suppression
of promoter activity was not observed. However, transfection of
a rat NRSF expression vector resulted in signi¢cant repression
of transcription, which was reversed by mutation of the NRSE.
In conclusion, we demonstrate that the GPR10 gene is speci¢-
cally regulated by NRSF, and suggest this to be a contributory
factor in the tissue-speci¢c distribution of GPR10 in vivo.
/ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
GPR10 (prolactin-releasing peptide receptor, hGR3) is a
member of the seven-transmembrane, G protein-coupled re-
ceptor superfamily [1], and is the human ortholog of rat un-
known hypothalamic receptor-1 [2]. Initially isolated from hy-
pothalamus, GPR10 was subsequently identi¢ed in various
other brain regions, with highest expression levels localized
to the reticular nucleus of the thalamus, the area postrema,
and the anterior pituitary [3^6]. Discovery of a speci¢c peptide
ligand using a method of reverse pharmacology [7] facilitated
the functional and pharmacological characterization of the
receptor [8^10], which led to the observation that GPR10
stimulates prolactin release in the anterior pituitary [7]. How-
ever, subsequent reports have led to the assertion that its
function in prolactin regulation may not be the primary role
of GPR10, as con£icting data have emerged in the literature
regarding temporal, spatial and environmental regulation of
this signaling pathway [11^13]. Intuitively, the distribution
pro¢le of GPR10 alone suggests alternative functions such
as a role in maintaining neuroendocrine and autonomic ho-
meostasis [4,5], and enhanced receptor levels in the dorsome-
dial hypothalamus substantiates this implication with the pos-
sible involvement of GPR10 in mechanisms of feeding. This
was con¢rmed by Lawrence et al., who reported that a single
injection of prolactin-releasing peptide into rats resulted in a
signi¢cant reduction in food intake with no obvious change in
behavior [11]. It remains to be seen whether GPR10 may be a
candidate target for therapeutic intervention in the treatment
of obesity. While the physiological roles of GPR10 continue
to be addressed, so the transcriptional regulation of the gene
also is under investigation. Putative binding sites for tran-
scription factors including Pit-1, Ptx-1, AP-1 and Sp1 have
been identi¢ed in the cloned 5P £anking region of the gene
[14], and regulation of the promoter activity by forskolin and
bromocryptine was shown to be indirectly mediated by CREB
[15]. However, no regulatory evidence has been reported to
justify its tissue-speci¢c distribution. We therefore examined
whether the restricted expression pro¢le of GPR10 may be
conferred by transcriptional regulation of the gene via speci¢c
elements in the 5P promoter. One particular cis-regulatory
element that directs mature neuronal and endocrine cell-spe-
ci¢c expression is NRSE (neuron-restrictive silencer element
[16]), also commonly referred to as RE-1 (repressor element-1
[17]). This 21-bp sequence confers transcriptional repression
of genes in many non-neuronal cell types by binding the zinc
¢nger transcriptional repressor NRSF (neuron-restrictive si-
lencer factor [18]) or REST (RE-1 silencing transcription fac-
tor [19]). When bound, NRSF recruits the co-repressor mSin3
and/or coREST causing repression of gene expression, possi-
bly by induction of hypoacetylation of histone and the remod-
eling of the chromatin structure [20^22]. However, in mature
neuronal and endocrine cells repression is alleviated [18,19,
23]. This de-repression is achieved either through attenuation
of NRSF expression, or by the relative increase in alterna-
tively spliced NRSF mRNA, generating truncated dominant
negative isoforms such as REST4 that interfere with NRSF
function [24^26]. An elegant example of this repressor mech-
anism was reported by Chen et al. who targeted the disruption
of NRSF in embryonic mice, causing a de-repression of neu-
ron-speci¢c tubulin expression in non-neuronal tissue [27].
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Thus, transcriptional regulation by NRSE/NRSF confers an
established mechanism of tissue-speci¢c gene expression.
Here, we demonstrate that the GPR10 gene promoter ex-
hibits a functional NRSE in the 5P £anking region, and pro-
pose that the observed tissue distribution of this receptor may
be in£uenced by NRSF activity.
2. Materials and methods
2.1. Cell lines
All cell culture reagents were purchased from Life Technologies
(Grand Island, NY, USA) except fetal bovine serum (FBS) (Omega
Scienti¢c, Tarzana, CA, USA). GH3 cells were cultured in Ham’s F12
medium with 2 mM L-glutamine, and supplemented with 15% horse
serum (HS) and 2.5% FBS. C6 cells were cultured in RPMI with 10%
FBS and 5% HS. Both 3T3 and HeLa cells were cultured in Dulbec-
co’s modi¢ed Eagle’s medium, supplemented with 10% FBS. All me-
dia contained 100 U/ml penicillin and 100 Wg/ml streptomycin.
2.2. Gel-shift assays
Nuclear extracts from 3T3 cells were prepared essentially as de-
scribed previously [28], and protein concentrations were determined
using the BCA kit (Pierce, Rockford, IL, USA). Double-stranded
oligonucleotides containing two tandem copies of the GPR10-NRSE
(5P-CCAGC GGAAG CTGTC CGTGG TGCTG ACTCC TGCCT
G-3P) were synthesized, and end-labeled using the Klenow fragment of
DNA polymerase I in the presence of [K-32P]dATP. Free nucleotides
were separated by centrifugation through a G-50 column. DNA^pro-
tein binding reactions were carried out in 20 Wl ¢nal volume of reac-
tion bu¡er containing 10 mM Tris (pH 7.6), 50 mM NaCl, 0.5 mM
dithiothreitol, 0.5 mM EDTA, 1 mM MgCl2, 5% glycerol and 250 Wg
of poly(dI-dC) per ml. The nuclear extract (10 Wg of protein) was
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Identi¢cation of a complex-forming NRSE in the 5P £anking region of the GPR10 gene. A: Alignment of the consensus sequence de-
rived from 29 functional NRSEs with the putative NRSE in the human GPR10 promoter. The nucleotides marked by asterisks were mutated
to thymidine residues in the mutant competitor oligonucleotide shown in C. B: The partial nucleotide sequences of the cloned human gene
aligned with the corresponding sequence from the mouse genome. The putative NRSF binding site is highlighted in the shaded box. C: Gel
shift to show sequence-speci¢c binding activity of NRSF to the human GPR10 NRSE. A 32P-labeled probe consisting of two tandem repeats
of the GPR10 NRSE was incubated with 3T3 cell nuclear extracts.
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added to the reaction bu¡er in the absence or presence of unlabeled
competitor DNA (SCG10^36 5P-GCAAA GCCAT TTCAG CACCA
CGGAG AGTGC CTCTG C-3P and SCG10^m36 5P-GCAAA
GCCAT TTCAG CACCA CTTAG AGTGC CTCTG C-3P) and
pre-incubated for 10 min on ice. Radiolabeled probe (20 000 cpm)
was then added and the mixture was incubated for a further 20 min
on ice. Electrophoresis to resolve DNA^protein complexes was per-
formed in 4% non-denaturing polyacrylamide gels in 0.25U Tris-bo-
rate^EDTA bu¡er at 150 V for 2^3 h.
2.3. Transient transfections and reporter gene assays
The cloned reporter gene constructs 34015, 32627, 31317 and
3642 containing various lengths of the 5P £anking region of the
GPR10 gene were generously provided by Dr. Kazuo Chihara,
Kobe University School of Medicine, Japan. Site-directed mutagenesis
of the 32627 construct to introduce two juxtaposed mutations within
the NRSE was generated using the Stratagene QuikChange, site-di-
rected mutagenesis kit (Stratagene, La Jolla, CA, USA). Mutation
was con¢rmed by DNA sequence analysis. Rat NRSF cDNA cloned
into pcDNA3 was a kind gift from Dr. Tonis Timmusk, University of
Helsinki, Finland.
Cells were plated in 24-well plates and grown overnight or until 75^
80% con£uent and then transfected using Lipofectamine 2000 accord-
ing to the manufacturer’s procedure (Invitrogen, Carlsbad, CA,
USA). 400 ng of reporter gene construct or pGL3 basic vector alone
was co-transfected into the cells along with 1 ng of pRL-CMV con-
taining the cDNA encoding Renilla luciferase (Promega, Madison,
WI, USA) to normalize the luciferase activity. When necessary, 1 Wg
of rat NRSF expression vector was co-transfected, and controlled
with 1 Wg of pcDNA3. After transfection, cells were incubated for
5 h in serum- and antibiotic-free medium and then for a further
48 h in normal growth medium. Cells were then lysed and measure-
ments of luciferase activity were performed using the dual luciferase
assay system (Promega) in conjunction with a AutolumatPlus dual
injection port luminometer (Berthold, Bad Wildbad, Germany). Fire-
£y luciferase values were normalized with the Renilla luciferase activ-
ity of co-transfected pRL-CMV. Values are expressed as multiples of
induction relative to the basic activity of pGL3.
2.4. RNA extraction and RT-PCR
Whole cell RNA was extracted by using the RNeasy Kit (Qiagen,
Valencia, CA, USA) in accordance with the manufacturer’s speci¢ca-
tions. Total RNA (5 Wg) was combined with 0.5 Wg of oligo(dT)16 and
heated to 65‡C for 10 min, then cooled on ice. RT bu¡er, dNTPs (50
WM each), dithiothreitol (5 mM), SuperScript II enzyme (50 units)
(Life Technologies, Rockville, MD, USA) and H2O were added for
a total volume of 20 Wl, and reactions were incubated at 42‡C for 40
min. PCR reactions were carried out in 100 Wl volume using 1 Wl of
cDNA template. Reactions contained 20 pmol each of forward and
reverse primers, 0.2 mM each of dNTPs and 2.5 U of thermostable
Fig. 2. Cell-speci¢c expression pattern of GPR10 promoter constructs. A: Schematic representation of the reporter gene constructs used for
transient transfections from fragments of the cloned human GPR10 gene promoter region. B: Cells were transiently transfected with the corre-
sponding reporter gene constructs represented above. Fire£y luciferase reporter activity was normalized to Renilla luciferase activity from a co-
transfected internal control plasmid (pRL-CMV). Each experiment was performed at least three times in quadruplicate. Results are expressed
as meanRS.E.M.
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Taq polymerase (TaKaRa Biomedical, Berkeley, CA, USA). Oligonu-
cleotides: NRSF+: 5P-CGCTG TGACC GCTGT GGCTA CAATA
C-3P, and NRSF3 : 5P-GGGCA ATTAA GAGGT TTAGG-3P were
used to amplify rat NRSF. For rat prolactin, PRL+: 5P-GCCAA
GTGTC AGCCC GGAAA-3P and PRL3 : 5P-GGCTT GTTCC
TTGTC TTCAG G-3P oligonucleotides were used. The rat insulin
and L-actin primers have been reported previously [29].
Speci¢c PCR ampli¢cation was con¢rmed by restriction digestion
and direct sequencing after cloning the corresponding fragment into
the pCRII TA cloning system (Invitrogen, San Diego, CA, USA).
3. Results and discussion
3.1. Identi¢cation of a putative NRSE in the 5P regulatory
region of the GPR10 gene
We used the on-line transcription factor database TRANS-
FAC to screen the 5P £anking region (approx. 4.0 kb) of the
human GPR10 gene [14]. This provided evidence for a highly
conserved putative NRSE located at position 31018 to 31038
relative to the translational start site. Orientation of the
NRSE has been con¢rmed as inconsequential to function by
various investigators [30^32], and in the GPR10 promoter the
sequence is located 3P to 5P on the reverse DNA strand. Align-
ment with the consensus sequence revealed 86% (18/21 bp)
identity (Fig. 1A). To determine the probability that this
site was indeed a functional binding site, and not simply a
false positive return, we performed an inter-species compara-
tive genomic sequence analysis. Inter-species conservation of
non-coding sequences is a powerful approach to identifying
regulatory elements, as speci¢cally conserved sequences sug-
gest relevance [33]. Alignment with the mouse genome showed
that the sequence was conserved to 87% identity, whereas
peripheral sequences were poorly conserved (40% identity)
(Fig. 1B). Furthermore, the few mismatches within the
NRSE were at non-essential nucleotides with respect to
NRSE/NRSF function, as established by statistical analysis
of nucleotide conservation in known functional NRSEs [30].
We then performed electromobility shift assays to deter-
mine whether the isolated sequence could bind NRSF (Fig.
1C). An oligonucleotide comprising two tandem 36-bp repeats
from the GPR10 gene promoter was used as probe (see Fig.
1B). A single band was generated when 3T3 cell nuclear ex-
tract was incubated with the radiolabeled probe. This complex
could be competed out by the unlabeled SCG10 gene NRSE
sequence, but not by the same sequence containing a well-
characterized double base pair mutation (see Fig. 1A). This
indicated that the putative NRSE within the GPR10 gene
promoter was suitable for speci¢c binding by NRSF, further
suggesting that this NRSE is functionally signi¢cant.
3.2. NRSF confers repression of promoter activity
We next addressed the functional signi¢cance of this ele-
ment, based on a series of reporter gene studies. Constructs
of increasing 5P deleted portions of the GPR10 gene promoter,
designed around the pGL3-basic reporter vector were em-
ployed to determine promoter activation levels (Fig. 2A)
[14]. Using three cell lines known to impart transcriptional
repression of genes via the NRSE, along with the anterior
pituitary cell line GH3, which is known to express the
GPR10 gene, we compared the expression levels of the report-
er constructs (Fig. 2B). In HeLa, C6, and 3T3 cells, highest
expression levels were observed with the 3642 construct,
whereas in all three cell lines, the 31317 construct displayed
a signi¢cantly attenuated level of reporter gene activity. This
was consistent with the fact that the NRSE is located at
31018^1038. In contrast, in GH3 cells there was no apparent
attenuation of reporter gene expression.
RT-PCR was employed to ascertain whether NRSF was
expressed in GH3 cells (Fig. 3A). C6 cells were used as a
positive control and the INS-1 pancreatic L-cell line was
used as a negative control. NRSF gene expression has been
reported to be absent from INS-1 cells, allowing the expres-
sion of several genes in these cells that are suppressed in non-
neuronal cells by NRSF [34,35]. As expected, only INS-1 cells
expressed insulin, and only GH3 cells expressed prolactin.
NRSF transcripts were detected in C6 cells but no product
was observed from either GH3 cells or INS-1 cells. These data
suggest therefore that the lack of repression of GPR10 pro-
moter activity in GH3 cells, shown in Fig. 2B, is due to the
absence of full-length NRSF in these cells.
To determine whether NRSF-mediated repression could be
Fig. 3. Co-transfection of NRSF induces susceptibility of GH3 cells
to NRSE-mediated repression of GPR10 promoter activity.
A: Whole cell RNA from C6, GH3, and INS-1 cells was subjected
to RT-PCR and the products separated by electrophoresis. B: Cells
were co-transfected with the indicated reporter gene construct and
either an NRSF expression vector or a control vector. Expression
levels were then presented as the ratio of reporter gene activities be-
tween the two conditions. The hatched bars represent constructs
that carry the putative NRSE. Luciferase activities were normalized
using pRL-CMV. Each experiment was performed at least three
times in quadruplicate. Results are expressed as meanRS.E.M.
(*P6 0.05).
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introduced into the GH3 cell context, we co-expressed either
an NRSF expression vector or a null expression vector into
these cells. Relative expression levels were analyzed to indicate
whether each construct was susceptible to inhibition by
NRSF. As expected, the 3642 construct displayed no relative
change in expression in the presence of NRSF (Fig. 3B).
However, the longer constructs, containing the NRSE motif,
showed a signi¢cant decrease in reporter gene expression level,
suggesting that the promoter is indeed repressed by NRSF,
and further supporting the idea that the putative NRSE in the
GPR10 gene promoter is functionally signi¢cant.
Notably, the full-length 34015 construct displayed an atte-
nuated expression level compared with the 31317 construct in
GH3 cells (Fig. 2B). This circumstance is paradoxical given
that GPR10 is expressed in GH3 cells [9,10,14]. The most
plausible explanation for this discrepancy is that regulatory
elements in other regions of the gene may play important
functional roles in the endogenous expression of this receptor.
 
Fig. 4. Point mutation of the NRSE sequence alleviates repression. A: A site-speci¢c mutation was introduced into the 32627 clone and subse-
quently sequenced. The alignment to the wild-type sequence is shown. The boxed region represents the NRSE, and the shaded areas highlight
the speci¢c mutations. B: The wild-type or mutant reporter genes were transiently transfected into C6 cells. C: Wild-type and mutant reporter
vectors were transiently co-transfected into GH3 cells with either the NRSF expression plasmid or the control plasmid. Luciferase activities
were normalized using pRL-CMV Renilla. Each experiment was performed at least three times in quadruplicate. Results are expressed as
meanRS.E.M. (**P6 0.01, ***P6 0.001, NS, not signi¢cant).
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This does not a¡ect or compromise the rationale for this study
however, as even with the 34015 construct, co-expression of
NRSF imparted a similar relative repression in reporter gene
expression to that seen with the shorter constructs containing
NRSE (Fig. 3).
3.3. Repression is speci¢cally mediated by the NRSE
To con¢rm that NRSF-mediated repression was directed
speci¢cally through the NRSE, we introduced a site-directed
mutation in the 32627 construct. By mutating the two juxta-
posed cytosine residues to adenine residues in the NRSE mo-
tif, we created a loss of function mutation (Fig. 4A). This
mutation has previously been shown to inactivate the NRSE
of the SCG10 and IB1 genes among others by abolishing
DNA binding of the repressor, and hence, its silencing activity
[18,35]. When compared with the wild-type construct in C6
cells, the expression level of the mutant construct was en-
hanced over 10-fold (Fig. 4B). This marked de-repression in
reporter gene expression o¡ers strong evidence that this ele-
ment is functional in the context of the GPR10 promoter.
In GH3 cells, both wild-type and mutant constructs ex-
pressed similar levels of reporter gene (Fig. 4C). However,
when co-expressed with the NRSF expression vector, a sig-
ni¢cant di¡erence was observed. Whereas activity of the wild-
type construct was inhibited signi¢cantly, no attenuation in
expression level was seen with the mutant construct, providing
further evidence that NRSF confers repression through the
NRSE in the GPR10 promoter.
We therefore propose that NRSF contributes to cell-speci¢c
expression of the human GPR10 gene. As this receptor may
prove to be an important target for therapeutic intervention
of obesity, it is important that the regulatory characteristics of
this gene be clearly recognized.
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